fashion -WSS

fashion

author：comprehensive 2025-10-02 00:41:04 - browse：59

MODERNA - Norwood facility — Alex Hogan/STAT

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

“We’re excited to move forward in our discussions with regulators, and hopefully continue to help address respiratory viruses globally,” Moderna President Stephen Hoge told STAT in an interview in which he acknowledged that the fall 2025 vaccine rollout is a target the company would like to hit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Physician assistants need a new name. Here's what it should be

WSS

STAT Virtual Event: JPM Recap, Live!

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

What to know about a major upcoming Wegovy heart health study

Stories you might have missed in 2023: health, science, medicine

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Merck to acquire Harpoon Therapeutics for $680 million

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

North Korean leader's powerful sister says warplanes repelled US spy plane

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA early review: GLP

In Memoriam: Notable people who died in 2023

Merck to acquire Harpoon Therapeutics for $680 million

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

focus

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

California man arrested in connection with serial murders of Mexican strip club workers

Why Titanic fascinates society, still drawing tours to the wreckage

Why Titanic fascinates society, still drawing tours to the wreckage

explore

leisure time

leisure time

hotspot